Fluoroquinolone Resistance: An Overview
DOI:
https://doi.org/10.14738/aivp.103.12338Abstract
In this review, we addressed different types and mechanisms of resistance to fluoroquinolones. Strategies to overcome resistance to these antimicrobials were discussed. The study showed that resistance by efflux was the reported type of mechanism of resistance varied with bacteria stains. For Enterobacteriaceas, plasmid mediated genese were responsible of the resistance but In Shigella, the resistance was due to chromosomal mutation. Helicobacter, Pseudomonas, Enterobacteria, Mycobacteria were found to be the most resistant microorganisms. To face the situation many strategies are usable such as rational antibiotic prescription, new compound discovery, antimicrobial and stewardships. The AWaRe concept is recently developed by the WHO as powerful tool to overcome antibiotic resistance.
References
Ashley, R. E., Lindsey Jr, R. H., McPherson, S. A., Turnbough Jr, C. L., Kerns, R. J., & Osheroff, N. (2017). Interactions between quinolones and Bacillus anthracis gyrase and the basis of drug resistance. Biochemistry, 56(32), 4191-4200. DOI: 10.1021/acs.biochem.7b00203.
Giedraitienė, A., Vitkauskienė, A., Naginienė, R., Pavilonis, A. Antibiotic Resistance Mechanisms of Clinically Important Bacteria. Medicina (Kaunas) 2011; 47(3):137-46.
Bryskier, A. ANTIMICROBIAL AGENTS: ANTIBACTERIALS AND ANTIFUNGALS. ASM PRESS; J4 ANT HD 6756.
Dhiman, P., Arora, N., Thanikachalam, P. V., & Monga, V. (2019). Recent advances in the synthetic and medicinal perspective of quinolones: A review. Bioorganic chemistry, 92, 103291.DOI : https://doi.org/10.1016/j.bioorg.2019.103291.
Versporten, A., Bielicki, J., Drapier, N., Sharland, M., and Goossens, H. The Worldwide Antibiotic Resistance and Prescribing in European Children (ARPEC) point prevalence survey: developing hospital-quality indicators of antibiotic prescribing for children. J. A. C. 2016; 71: 1106–17. Doi:10.1093/jac/dkv418.
Livermore, D. M. (2012). Current epidemiology and growing resistance of gram-negative pathogens. The Korean journal of internal medicine. 2012; 27:128-41. http://dx.doi.org/10.3904/kjim.2012.27.128.
Liwa, A. C, and Jaka, H. Antimicrobial resistance: Mechanisms of action of antimicrobial agents. The Battle against Microbial Pathogens: Basic Science, Technological Advances and Educational Programs (A. Méndez-Vilas, Ed.) FORMATEX 2015; 876-85.
Spellberg, B. The New Antibiotic Mantra----“Shorter Is Better”. JAMA. Intern. Med. 2016; 176(9):1254-5; doi: 10.1001/jamainternmed.2016.3646.
Hooper, D. C. and Jacoby, G. A. Topoisomerase Inhibitors: Fluoroquinolone Mechanisms of Action and Resistance. Cold Spring Harb Perspect Med 2016; 6:a025320. Doi: 10.1101/cshperspect.a025320.
Hooper, D. C. and Jacoby, G. A. Mechanisms of drug resistance: quinolone resistance. Ann. N. Y. Acad. Sci. ISSN 0077-8823; doi: 10.1111/nyas.12830.
Livermore, D. M. Evolution of antimicrobial resistance: what will happen next in the bugs? Antimicrob. Agents. Chemother. 2009; 53:4472-8.
Guilhelmelli, F., Vilela, N., Albuquerque. P., Derengowski, L. S., Silva-Pereira, I., and Kyaw, C. M. Antibiotic development challenges: the various mechanisms of action of antimicrobial peptides and of bacterial resistance. Frontiers in Microbiology 2013; 4(353):1-13; https://doi.org/10.3389/fmicb.2013.00353.
O’NEILL, J. TACKLING DRUG-RESISTANT INFECTIONS GLOBALLY: FINAL REPORT AND RECOMMENDATIONS. Rev. Antimic. Res. 2016; 1-84.
Kariuki, S. and Dougan, G. Antibacterial resistance in sub-Saharan Africa: an underestimated emergency. Ann. N. Y. Acad. Sci. 2014; 1323(1):43-55; doi: 10.1111/nyas.12380.
Vasoo, S., Barreto, J. N., and Tosh, P. K. Emerging issues in Gram-Negative Bacterial Resistance: An Update for the Practicing Clinician. Mayo Clin Proc. 2015; 90(3):395-403; http://dx.doi.org/10.1016/j.mayocp.2014.12.002.
Leekha, S., Terrell, C. L., and Edson, R. S. General Principles of Antimicrobial Therapy. Mayo. Clin. Proc. 2011; 86(2): 156-67. Doi:10.4065/mcp.2010.0639.
Theuretzbacher, U. Global antibacterial resistance: The never-ending story. J. Glob. Antic. Resist. 2013; 1(2), 63-69; https://doi.org/10.1016/j.jgar.2013.03.010.th
W. H. O. Critically Important Antimicrobials for Human Medicine. AGISAR. 6 Rev2018; ISBN 978 92 4 151552-8.
Asokan, G. V., & Vanitha, A. (2018). WHO global priority pathogens list on antibiotic resistance: an urgent need for action to integrate One Health data. Perspectives in public health, 138(2), 87-88. ISSN 1757-9139. DOI: 10.1177/1757917743881.
Džidic, S., Šuškovic, J., Kos, B. Antibiotic resistance mechanisms in bacteria: biochemical and genetic aspects. Food. Technol. Biotechnol. 2008; 46:11-21.
Alekshun, M. N., Levy, S. B. Molecular mechanism of antibacterial multidrug resistance. Cell. 2007; 128:1037-50. https://doi.org/10.1016/j.cell.2007.03.004
Lemaoui, C. E., Layaida, H., Badi, A., Foudi, N. Strategies actuelles de lutte contre la résistance aux antibiotiques. Journal des anti-infectieux. 2017; 19(1) : 12 – 19. DOI : 10.1016/j.antinf.2017.01.003.
Jaka, H., Rüttgerodt, N., Bohne, W., Mueller, A., Gross, U., Kasang, C., Mshana, S. E. Helicobacter pylori Mutations Conferring Resistance to Fluoroquinolones and Clarithromycin among Dyspeptic Patients Attending a Tertiary Hospital, Tanzania. Can. J. Gastroenterol. Hepatol. 2019 Jul 1; 2019:8481375. DOI: 10.1155/2019/8481375. PMID:
Ahmad, N., Javaid, A., Sulaiman, S. A., Ming, L. C., Ahmad, I., Khan, A. H. Resistance patterns, prevalence, and predictors of fluoroquinolones resistance in multidrug resistant tuberculosis patients. Braz J Infect Dis. 2016 Jan-Feb; 20(1):41-7. doi: 10.1016/j.bjid.2015.09.011. Epub 2015 Nov 25. PMID: 26626164.
Kotb, D. N., Mahdy, W. K., Mahmoud, M. S., Khairy, R. M. M. Impact of co-existence of PMQR genes and QRDR mutations on fluoroquinolones resistance in Enterobacteriaceae strains isolated from community and hospital acquired UTIs. BMC Infect Dis. 2019 Nov 21; 19(1):979. DOI: 10.1186/s12879-019-4606-y. PMID: 31752702; PMCID: PMC6868749.
Farkas, A., Tarco, E., Butiuc-Keul, A. Antibiotic resistance profiling of pathogenic Enterobacteriaceae from Cluj-Napoca, Romania. Germs. 2019 Mar 1; 9(1):17-27. DOI: 10.18683/germs.2019.1153. PMID: 31119113; PMCID:
Meng, D. Y., Sun, C. J., Yu, J. B., Ma, J., Xue, W. C. Molecular mechanism of fluoroquinolones resistance in Mycoplasma hominis clinical isolates. Braz J Microbiol. 2014 May 19; 45(1):239-42. DOI: 10.1590/s1517-83822014000100034. PMID: 24948939; PMCID: PMC4059304.
Dumitru, E., Alexandrescu, L., Hanu, A. C., Tocia, C., Cozaru, G. C., Mitroi, A. F., Brînzan, C., Așchie, M., Dumitru, I. M. Genetic Antibiotic Resistance of Helicobacter pylori in South-Eastern Romania. J Gastrointestin Liver Dis. 2020 Mar 13; 29(1):19-25. DOI: 10.15403/jgld-758. PMID: 32176750.
Guo, X., Wang, H., Cheng, Y., Zhang, W., Luo, Q., Wen, G., Wang, G., Shao, H, Zhang, T. Quinolone resistance phenotype and genetic characterization of Salmonella enterica serovar Pullorum isolates in China, during 2011 to 2016. BMC Microbiol. 2018 Dec 27; 18(1):225. DOI: 10.1186/s12866-018-1368-4. PMID: 30587131; PMCID:
Martins, G. M., Sanches, B. S., Moretzsohn, L. D., Lima, K. S., Cota, B. D., Coelho, L. G. MOLECULAR DETECTION OF CLARITHROMYCIN AND FLUOROQUINOLONES RESISTANCE IN HELICOBACTER PYLORI INFECTION, DIRECTLY APPLIED TO GASTRIC BIOPSIES, IN AN URBAN BRAZILIAN POPULATION. Arq Gastroenterol. 2016 Apr-Jun; 53(2):113-7. DOI: 10.1590/S0004-28032016000200012. PMID: 27305419.
Kim, J. Y., Jeon, S. M., Kim, H., Park, M. S., Kim, S. H. A Contribution of MdfA to Resistance to Fluoroquinolones in Shigella flexneri. Osong Public Health Res Perspect. 2011 Dec; 2(3):216-7. DOI: 10.1016/j.phrp.2011.11.049. PMID:
Abdulla, A., Ewoldt, T. M. J., Hunfeld, N. G. M., Muller, A. E., Rietdijk, W. J. R., Polinder, S., van Gelder, T., Endeman, H., Koch, B. C. P. The effect of therapeutic drug monitoring of beta-lactam and fluoroquinolones on clinical outcome in critically ill patients: the DOLPHIN trial protocol of a multi-centre randomised controlled trial. BMC Infect Dis. 2020 Jan 17; 20(1):57. DOI: 10.1186/s12879-020-4781-x. PMID: 31952493; PMCID: PMC6969462.
Moya-Salazar, J., Terán-Vásquez, A., Salazar-Hernández, R. Alta resistencia antimicrobiana a Fluoroquinolonas por Campylobacter en pacientes pediátricos de un hospital peruano [High-Antimicrobial Resistance to Fluoroquinolones by Campylobacter in Pediatric Patients in a Peruvian Hospital]. Rev Peru Med Exp Salud Publica. 2018 Jan-Mar; 35(1):156-158. Spanish. DOI: 10.17843/rpmesp.2018.351.3607. PMID: 29924265.
Al-Hasan, M. N., Gould, A. P., Drennan, C., Hill, O., Justo, J. A., Kohn, J., Bookstaver, P. B. Empirical fluoroquinolones versus broad-spectrum beta-lactams for Gram-negative bloodstream infections in the absence of antimicrobial resistance risk factors. J Glob Antimicrob Resist. 2020 Sep; 22:87-93. DOI: 10.1016/j.jgar.2019.12.015. Epub 2019 Dec 27. PMID: 31887412.
Sharma, R., Sandrock, C. E., Meehan, J., Theriault, N. Community-Acquired Bacterial Pneumonia-Changing Epidemiology, Resistance Patterns, and Newer Antibiotics: Spotlight on Delafloxacin. Clin Drug Investig. 2020 Oct; 40(10):947-960. DOI: 10.1007/s40261-020-00953-z. Erratum in: Clin Drug Investig. 2021 Feb; 41(2):197. PMID:
Lee, H. W., Yim, J. J. Fluoroquinolone resistance in multidrug-resistant tuberculosis patients. Korean J Intern Med. 2019 Mar; 34(2):286-287. DOI: 10.3904/kjim.2019.045. Epub 2019 Feb 25. PMID: 30840810; PMCID:
Kaysin, A., Viera, A. J. Community-Acquired Pneumonia in Adults: Diagnosis and Management. Am Fam Physician. 2016 Nov 1; 94(9):698-706. Erratum in: Am Fam Physician. 2017 Apr 1; 95(7):414. PMID: 27929242.
Kang, M. H., Chae, M. J., Yoon, J. W., Lee, S. Y., Yoo, J. H., Park, H. M. Resistance to fluoroquinolones and methicillin in ophthalmic isolates of Staphylococcus pseudintermedius from companion animals. Can Vet J. 2014 Jul; 55(7):678-82. PMID: 24982521; PMCID: PMC4060912.
Wieczorek, K., Osek, J. Antimicrobial resistance mechanisms among Campylobacter. Biomed Res Int. 2013; 2013:340605. DOI: 10.1155/2013/340605. Epub 2013 Jun 24. PMID: 23865047; PMCID: PMC3707206.
Hecker, M. T., Son, A. H., Murphy, N. N., Sethi, A. K., Wilson, B. M., Watkins, R. R., Donskey. C. J. Impact of syndrome-specific antimicrobial stewardship interventions on use of and resistance to fluoroquinolones: An interrupted time series analysis. Am J Infect Control. 2019 Aug; 47(8):869-875. DOI: 10.1016/j.ajic.2019.01.026. Epub 2019 Mar 6. PMID: 30850252.
Walia, K., Madhumathi, J., Veeraraghavan, B., Chakrabarti, A., Kapil, A., Ray, P., Singh, H., Sistla, S., Ohri, V. C. Establishing Antimicrobial Resistance Surveillance & Research Network in India: Journey so far. Indian J Med Res. 2019 Feb; 149(2):164-179. DOI: 10.4103/ijmr.IJMR_226_18. PMID: 31219080; PMCID: PMC6563732. 547
Sanches, B. S., Martins, G. M., Lima, K., Cota, B., Moretzsohn, L. D., Ribeiro, L. T., Breyer, H. P., Maguilnik, I., Maia, A. B., Rezende-Filho, J., Meira, A. C., Pinto, H., Alves, E., Mascarenhas, R., Passos, R., de Souza, J. D., Trindade, O. R., Coelho, L. G. Detection of Helicobacter pylori resistance to clarithromycin and fluoroquinolones in Brazil: A national survey. World J Gastroenterol. 2016 Sep 7; 22(33):7587-94. DOI: 10.3748/wjg.v22.i33.7587. PMID:
Acheampong, G., Owusu, M., Owusu-Ofori, A., Osei, I., Sarpong, N., Sylverken, A., Kung, H. J., Cho, S. T., Kuo, C. H., Park, S. E., Marks, F., Adu-Sarkodie, Y., Owusu-Dabo, E. Chromosomal and plasmid-mediated fluoroquinolone resistance in human Salmonella enterica infection in Ghana. BMC Infect Dis. 2019 Oct 28; 19(1):898. DOI: 10.1186/s12879-019-4522-1. PMID: 31660876; PMCID: PMC6819380.
Ching, C., Orubu, E. S. F., Wirtz, V. J., Zaman, M. H. Bacterial antibiotic resistance development and mutagenesis following exposure to subminimal inhibitory concentrations of fluoroquinolones in vitro: a systematic literature review protocol. BMJ Open. 2019 Oct 30; 9(10):e030747. DOI: 10.1136/bmjopen-2019-030747. PMID: 31666265; PMCID: PMC6830604.
Shetty, S. S., Deekshit, V. K., Jazeela, K., Vittal, R., Rohit, A., Chakraborty, A., Karunasagar, I. Plasmid-mediated fluoroquinolone resistance associated with extra-intestinal Escherichia coli isolates from hospital samples. Indian J Med Res. 2019 Feb; 149(2):192-198. DOI: 10.4103/ijmr.IJMR_2092_17. PMID: 31219083; PMCID: PMC6563729.
Kabir, S., Tahir, Z., Mukhtar, N., Sohail, M., Saqalein, M., Rehman, A. Fluoroquinolone resistance and mutational profile of gyrA in pulmonary MDR tuberculosis patients. BMC Pulm Med. 2020 May 11; 20(1):138. DOI: 10.1186/s12890-020-1172-4. PMID: 32393213; PMCID: PMC7216623.
Martins, G. M., Sanches, B. S., Moretzsohn, L. D., Lima, K. S., Cota, B. D., Coelho, L. G. MOLECULAR DETECTION OF CLARITHROMYCIN AND FLUOROQUINOLONES RESISTANCE IN HELICOBACTER PYLORI INFECTION DIRECTLY APPLIED TO GASTRIC BIOPSIES, IN AN URBAN BRAZILIAN POPULATION. Arq Gastroenterol. 2016 Apr-Jun; 53(2):113-7. DOI: 10.1590/S0004-28032016000200012. PMID: 27305419.
Jia, W., Wang, J., Xu., H., Li, G. Resistance of Stenotrophomonas maltophilia to Fluoroquinolones: Prevalence in a University Hospital and Possible Mechanisms. Int J Environ Res Public Health. 2015 May 13;12(5):5177-95. doi: 10.3390/ijerph120505177. PMID: 25985315; PMCID: PMC4454961.
Shen, G. H., Tsao, T. C., Kao, S. J., Lee, J. J., Chen, Y. H., Hsieh, W. C., Hsu, G. J., Hsu, Y. T., Huang, C. T., Lau, Y. J., Tsao, S. M., Hsueh, P. R. Does empirical treatment of community-acquired pneumonia with fluoroquinolones delay tuberculosis treatment and result in fluoroquinolone resistance in Mycobacterium tuberculosis? Controversies and solutions. Int J Antimicrob Agents. 2012 Mar;39(3):201-5. doi: 10.1016/j.ijantimicag.2011.11.014. Epub 2012 Jan 28. PMID: 22285045; PMCID: PMC7127649.
Al-Shaer, M. H., Alghamdi, W. A., Alsultan, A., An, G., Ahmed, S., Alkabab, Y., Banu, S., Barbakadze, K., Houpt, E., Kipiani, M., Mikiashvili, L., Cegielski, J. P., Kempke,r R. R., Heysell, S. K., Peloquin, C. A. Fluoroquinolones in Drug-Resistant Tuberculosis: Culture Conversion and Pharmacokinetic/Pharmacodynamic Target Attainment To Guide Dose Selection. Antimicrob Agents Chemother. 2019 Jun 24;63(7):e00279-19. doi: 10.1128/AAC.00279-19. PMID:
Deguchi, H., Kitazawa, K., Kayukawa, K., Kondoh, E., Fukumoto, A., Yamasaki, T., Kinoshita, S., Sotozono, C. The trend of resistance to antibiotics for ocular infection of Staphylococcus aureus, coagulase-negative staphylococci, and Corynebacterium compared with 10-years previous: A retrospective observational study. PLoS One. 2018 Sep 7;13(9):e0203705. doi: 10.1371/journal.pone.0203705. PMID: 30192856; PMCID: PMC6128643.
Britto, C. D., John, J., Verghese, V. P., Pollard, A. J. A systematic review of antimicrobial resistance of typhoidal Salmonella in India. Indian J Med Res. 2019 Feb;149(2):151-163. doi: 10.4103/ijmr.IJMR_830_18. PMID:
Mayer, C., Takiff, H. The Molecular Genetics of Fluoroquinolone Resistance in Mycobacterium tuberculosis. Microbiol Spectr. 2014 Aug;2(4):MGM2-0009-2013. doi: 10.1128/microbiolspec.MGM2-0009-2013. PMID:
Huguet, A., Pensec, J., Soumet, C. Resistance in Escherichia coli: variable contribution of efflux pumps with respect to different fluoroquinolones. J Appl Microbiol. 2013 May; 114(5):1294-9. doi: 10.1111/jam.12156. Epub 2013 Feb 18. PMID: 23414263.
www.https://who.int/publications/i/item/WHOEMPIAU2019.11. WHO AWaRe Classification Database of Antibiotics for evaluation and monitoring of use. WHO/EMP/IAU/2019.11.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Blaise DACKOUO
This work is licensed under a Creative Commons Attribution 4.0 International License.
